Article
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution.
eLife - 21 Feb 2023
Moulana Alief, Dupic Thomas, Phillips Angela M, Chang Jeffrey, Roffler Anne A, Greaney Allison J, Starr Tyler N, Bloom Jesse D, Desai Michael M
Abstract excerpt
The Omicron BA.1 variant of SARS-CoV-2 escapes convalescent sera and monoclonal antibodies that are effective against earlier strains of the virus. This immune evasion is largely a consequence of mutations in the BA.1 receptor binding domain (RBD), the major antigenic target of SARS-CoV-2. Previous studies have identified several key RBD mutations leading to escape from most antibodies. However, little is known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
